⌘K
t
Kosmos Energy Ltd's seven Directors—Roy A. Franklin, Deanna L. Goodwin, Sir John Douglas Kelso Grant, Maria Moraeus Hanssen, Adebayo O. Ogunlesi, Steven M. Sterin, and J. Michael Stice—were each granted 62,044 restricted share units on May 28, 2026, at a price of $2.74 per unit. Additionally, between May 27 and 28, 2026, Roy A. Franklin had 976 shares withheld and sold 43,466 shares, Sir John Douglas Kelso Grant had 735 shares withheld and sold 43,466 shares, and Steven M. Sterin sold 38,636 shares, all to cover tax liabilities from vested restricted share units.
| Date | 1 Jun 2026 |
| Time | 12:57:42 |
| Category | Director/PDMR dealings |
| ID | 5010G |
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
1 June 2026
The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:
|
PDMR |
Date of transaction |
No. of shares vested |
No. of shares granted |
No. of shares sold or withheld |
|
Roy A. Franklin |
27 May 2026 |
0 |
0 |
976 |
|
Roy A. Franklin |
28 May 2026 |
0 |
0 |
43,466 |
|
Roy A. Franklin |
28 May 2026 |
0 |
62,044 |
0 |
|
Deanna L. Goodwin |
28 May 2026 |
0 |
62,044 |
0 |
|
Sir John Douglas Kelso Grant |
27 May 2026 |
0 |
0 |
735 |
|
Sir John Douglas Kelso Grant |
27 May 2026 |
0 |
0 |
43,466 |
|
Sir John Douglas Kelso Grant |
28 May 2026 |
0 |
62,044 |
0 |
|
Maria Moraeus Hanssen |
28 May 2026 |
0 |
62,044 |
0 |
|
Adebayo O. Ogunlesi |
28 May 2026 |
0 |
62,044 |
0 |
|
Steven M. Sterin |
27 May 2026 |
0 |
0 |
38,636 |
|
Steven M. Sterin |
28 May 2026 |
0 |
62,044 |
0 |
|
J. Michael Stice |
28 May 2026 |
0 |
62,044 |
0 |
The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
Josh R. Marion
Senior Vice President, General Counsel and Corporate Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
[email protected]
Media Relations
Thomas Golembeski
+1-214-445-9674
[email protected]
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Roy A. Franklin |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
976 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan"). |
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
2.85 |
|
|
Volume |
976 |
|
|
Total |
2,781.60 |
|
|
e) |
Aggregated information |
|
|
Price |
2.85 |
|
|
Volume |
976 |
|
|
Total |
2,781.60 |
|
|
f) |
Date of the transactions |
27 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
43,466 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan. |
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
2.73 |
|
|
Volume |
43,466 |
|
|
Total |
118,662.18 |
|
|
e) |
Aggregated information |
|
|
Price |
2.73 |
|
|
Volume |
43,466 |
|
|
Total |
118,662.18 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Deanna L. Goodwin |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Sir John Douglas Kelso Grant |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
735 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan"). |
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
2.85 |
|
|
Volume |
735 |
|
|
Total |
2,094.75 |
|
|
e) |
Aggregated information |
|
|
Price |
2.85 |
|
|
Volume |
735 |
|
|
Total |
2,094.75 |
|
|
f) |
Date of the transactions |
27 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
43,466 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan. |
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
2.73 |
|
|
Volume |
43,466 |
|
|
Total |
118,615.59 |
|
|
e) |
Aggregated information |
|
|
Price |
2.73 |
|
|
Volume |
43,466 |
|
|
Total |
118,615.59 |
|
|
f) |
Date of the transactions |
27 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Maria Moraeus Hanssen |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Adebayo O. Ogunlesi |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
Steven M. Sterin |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
38,636 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan. |
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
2.73 |
|
|
Volume |
38,636 |
|
|
Total |
105,476.28 |
|
|
e) |
Aggregated information |
|
|
Price |
2.73 |
|
|
Volume |
38,636 |
|
|
Total |
105,476.28 |
|
|
f) |
Date of the transactions |
27 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
a) |
Name |
J. Michael Stice |
|
b) |
Position / status |
Director |
|
c) |
Initial notification / amendment |
Initial notification |
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Common Shares, par value $0.01 per share |
|
b) |
Nature of the transactions |
62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
|
Shares granted or vested |
||
|
c) |
Currency |
USD |
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
Shares sold or withheld |
||
|
d) |
Currency |
USD |
|
Price |
0 |
|
|
Volume |
0 |
|
|
Total |
0 |
|
|
e) |
Aggregated information |
|
|
Price |
2.74 |
|
|
Volume |
62,044 |
|
|
Total |
170,000 |
|
|
f) |
Date of the transactions |
28 May 2026 |
|
g) |
Place of the transaction |
NYSE |